Infectious diseases. Source of new hope against malaria is in short supply.
Enserink
Martin
M
D000349:Africa; D000818:Animals; D000962:Antimalarials / Q000191:economics / Q000600:supply & distribution* / Q000627:therapeutic use; D037621:Artemisinins / Q000191:economics / Q000600:supply & distribution* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D016527:Drug Costs; D015195:Drug Design; D004353:Drug Evaluation, Preclinical; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D004363:Drug Utilization; D005818:Genetic Engineering; D006573:Heterocyclic Compounds, 1-Ring / Q000737:chemistry / Q000494:pharmacology; D006801:Humans; D008288:Malaria / Q000188:drug therapy*; D010545:Peroxides / Q000737:chemistry / Q000494:pharmacology; D010963:Plasmodium falciparum / Q000187:drug effects; D013141:Spiro Compounds / Q000737:chemistry / Q000494:pharmacology; D014944:World Health Organization
D000962:Antimalarials; D037621:Artemisinins; D006573:Heterocyclic Compounds, 1-Ring; D010545:Peroxides; D013141:Spiro Compounds; C489136:arterolane